PolyTouch gains FDA nod

PolyTouch Medical has developed a device for laparoscopic hernia repair.

Misgav Venture Accelerator portfolio company PolyTouch Medical Ltd. has obtained US Food and Drug Administration (FDA) approval for the company's PatchAssist laparoscopic hernia mesh placement device.

PolyTouch says that the PatchAssist enables accurate mesh placement in ventral hernia repaid, reducing the surgical procedure time by 30%-50%.

PolyTouch CEO Ofek Levin said, "There's a very great deal of interest from both surgeons and companies in the business. We believe that the PolyTouch's device will become the new standard for the deployment and placement of meshes in laparoscopic procedures."

Misgav CEO Dr. Eran Feldhay said that the FDA approval was obtained quite quickly, just 49 days after PolyTouch filed a Premarket 510(k) Application. He said that this was a vote of confidence by the FDA in the company's technology.

Published by Globes [online], Israel business news - www.globes-online.com - on June 21, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018